{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "06",
                "@timestamp": "2022-09-06T01:56:56.000056-04:00",
                "@year": "2022",
                "@month": "09"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "08"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding-addon-generated-timestamp": "2022-08-12T04:47:51.744Z",
            "xocs:funding-text": "We sincerely thankful to our patient for giving us opportunity to treat her. Special thanks to our general medicine staff who help provided us the database.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/nlp-car"
        }},
        "bibrecord": {
            "head": {
                "author-group": {
                    "affiliation": {
                        "country": "Thailand",
                        "@afid": "60002620",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Division of Medical Oncology"},
                            {"$": "Department of Medicine"},
                            {"$": "Faculty of Medicine"},
                            {"$": "King Chulalongkorn Memorial Hospital and Chulalongkorn University"}
                        ],
                        "affiliation-id": [
                            {
                                "@afid": "60002620",
                                "@dptid": "126188480"
                            },
                            {"@afid": "60022183"},
                            {"@afid": "60028190"}
                        ],
                        "@affiliation-instance-id": "2014128158-25579cefc2e569091d5071d48d978069",
                        "ce:source-text": "Division of Medical Oncology, Department of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital and Chulalongkorn University, Bangkok, Thailand",
                        "@dptid": "126188480"
                    },
                    "author": [
                        {
                            "ce:given-name": "Chalita",
                            "preferred-name": {
                                "ce:given-name": "Chalita",
                                "ce:initials": "C.",
                                "ce:surname": "Lagampan",
                                "ce:indexed-name": "Lagampan C."
                            },
                            "@author-instance-id": "2014128158-1abd69b44207851ebf14392e94e32607",
                            "@seq": "1",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Lagampan",
                            "@auid": "57218290182",
                            "ce:indexed-name": "Lagampan C."
                        },
                        {
                            "ce:given-name": "Nattaya",
                            "preferred-name": {
                                "ce:given-name": "Nattaya",
                                "ce:initials": "N.",
                                "ce:surname": "Poovorawan",
                                "ce:indexed-name": "Poovorawan N."
                            },
                            "@author-instance-id": "2014128158-f351769e55384b9dcdeaa1d17537c072",
                            "@seq": "2",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Poovorawan",
                            "@auid": "57192107420",
                            "ce:indexed-name": "Poovorawan N."
                        },
                        {
                            "ce:given-name": "Napa",
                            "preferred-name": {
                                "ce:given-name": "Napa",
                                "ce:initials": "N.",
                                "ce:surname": "Parinyanitikul",
                                "ce:indexed-name": "Parinyanitikul N."
                            },
                            "@author-instance-id": "2014128158-4484046faa0cb8f90d2290d82b06fd20",
                            "@seq": "3",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Parinyanitikul",
                            "@auid": "36554719100",
                            "ce:indexed-name": "Parinyanitikul N."
                        }
                    ]
                },
                "citation-title": "Lactic acidosis, a potential toxicity from drug\u2013drug interaction related to concomitant ribociclib and metformin in preexisting renal insufficiency: A case report",
                "abstracts": "© 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC.Background: Ribociclib, one of the cyclin-dependent kinases (CDK) 4 and 6 inhibitors, in combination with endocrine therapies has been approved in the treatment of hormonal receptor positive, HER-2 negative metastatic breast cancer worldwide. Long-term usage of ribociclib with concomitant drugs, potential drug\u2013drug interaction may develop which can limit the therapeutic value of CDK4/6 inhibitor. Case: A 62-year-old with history of non-insulin dependent diabetic, dyslipidemia, and essential hypertension was diagnosed with HR-positive, HER-2 negative metastatic breast cancer and treated with fulvestrant plus ribociclib. Four weeks after administration, elevated serum creatinine was observed, and then severe lactic acidosis with acute respiratory failure was subsequently reported. Ribociclib and fulvestrant were temporarily discontinued. Three days after renal replacement therapy, her clinical was stabilized. Combination ribociclib with metformin resulted in high plasma metformin levels and dangerous consequences. Hence, special precaution should be considered during concomitant treatment with sensitive transporter substrates. Conclusion: Metformin associated lactic acidosis may potentially occur after combination with ribocilib, an uncommon but lethal complication from the interaction of these drugs, especially in patients who had preexisting renal impairment.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Division of Medical Oncology"},
                            {"$": "Department of Medicine"},
                            {"$": "Faculty of Medicine"},
                            {"$": "King Chulalongkorn Memorial Hospital and Chulalongkorn University"}
                        ],
                        "ce:source-text": "Division of Medical Oncology, Department of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital and Chulalongkorn University, Bangkok, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Napa",
                        "ce:initials": "N.",
                        "ce:surname": "Parinyanitikul",
                        "ce:indexed-name": "Parinyanitikul N."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "concomitant",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "drug\u2013drug interaction",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "lactic acidosis",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "renal insufficiency",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://onlinelibrary.wiley.com/journal/25738348",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "volisspag": {"voliss": {
                        "@volume": "5",
                        "@issue": "8"
                    }},
                    "@type": "j",
                    "sourcetitle": "Cancer Reports",
                    "publicationdate": {
                        "month": "08",
                        "year": "2022",
                        "date-text": "August 2022",
                        "day": "01"
                    },
                    "sourcetitle-abbrev": "Cancer Rep.",
                    "@country": "usa",
                    "issn": {
                        "$": "25738348",
                        "@type": "electronic"
                    },
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "John Wiley and Sons Inc"},
                    "article-number": "e1575",
                    "@srcid": "21100983151"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "28",
                                    "classification-description": "Urology and Nephrology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2730"},
                                {"$": "1306"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "MEDI"},
                                {"$": "BIOC"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "esbd",
                        "chemical": [
                            {
                                "cas-registry-number": "88150-42-9",
                                "chemical-name": "amlodipine"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "144-55-8"},
                                    {"$": "71-52-3"}
                                ],
                                "chemical-name": "bicarbonate"
                            },
                            {
                                "cas-registry-number": "154361-50-9",
                                "chemical-name": "capecitabine"
                            },
                            {
                                "cas-registry-number": "16887-00-6",
                                "chemical-name": "chloride"
                            },
                            {
                                "cas-registry-number": "9001-15-4",
                                "enzyme-commission-number": "EC 2.7.3.2",
                                "chemical-name": "creatine kinase"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "19230-81-0"},
                                    {"$": "60-27-5"}
                                ],
                                "chemical-name": "creatinine"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "50-18-0"},
                                    {"$": "6055-19-2"}
                                ],
                                "chemical-name": "cyclophosphamide"
                            },
                            {
                                "cas-registry-number": "114977-28-5",
                                "chemical-name": "docetaxel"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "23214-92-8"},
                                    {"$": "25316-40-9"}
                                ],
                                "chemical-name": "doxorubicin"
                            },
                            {
                                "cas-registry-number": "129453-61-8",
                                "chemical-name": "fulvestrant"
                            },
                            {
                                "cas-registry-number": "29094-61-9",
                                "chemical-name": "glipizide"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "50-99-7"},
                                    {"$": "84778-64-3"}
                                ],
                                "chemical-name": "glucose"
                            },
                            {
                                "cas-registry-number": "112809-51-5",
                                "chemical-name": "letrozole"
                            },
                            {
                                "cas-registry-number": "114798-26-4",
                                "chemical-name": "losartan"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "1115-70-4"},
                                    {"$": "657-24-9"}
                                ],
                                "chemical-name": "metformin"
                            },
                            {
                                "cas-registry-number": "33069-62-4",
                                "chemical-name": "paclitaxel"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "571190-30-2"},
                                    {"$": "827022-33-3"}
                                ],
                                "chemical-name": "palbociclib"
                            },
                            {
                                "cas-registry-number": "7440-09-7",
                                "chemical-name": "potassium"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "1211441-98-3"},
                                    {"$": "1374639-75-4"}
                                ],
                                "chemical-name": "ribociclib"
                            },
                            {
                                "cas-registry-number": "79902-63-9",
                                "chemical-name": "simvastatin"
                            },
                            {
                                "cas-registry-number": "7440-23-5",
                                "chemical-name": "sodium"
                            },
                            {
                                "cas-registry-number": "10540-29-1",
                                "chemical-name": "tamoxifen"
                            }
                        ]
                    }}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "We sincerely thankful to our patient for giving us opportunity to treat her. Special thanks to our general medicine staff who help provided us the database.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "24",
                    "@timestamp": "BST 03:28:43",
                    "@year": "2022",
                    "@month": "08"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2014128158",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "936604396",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20211030562",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "34739192",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20214559505",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20213720399",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20219011419459",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85118498186",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85118498186",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.1002/cnr2.1575"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "20",
                "reference": [
                    {
                        "ref-fulltext": "Gao JJ, Cheng J, Bloomquist E, et al. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis. Lancet Oncol. 2020;21(2):250-260.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85078499000",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "250",
                                    "@last": "260"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Gao",
                                        "ce:indexed-name": "Gao J.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Cheng",
                                        "ce:indexed-name": "Cheng J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Bloomquist",
                                        "ce:indexed-name": "Bloomquist E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Gao JJ, Cheng J, Bloomquist E, et al. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis. Lancet Oncol. 2020;21(2):250-260."
                    },
                    {
                        "ref-fulltext": "Spring LM, Wander SA, Andre F, Moy B, Turner NC, Bardia A. Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future. Lancet. 2020;395(10226):817-827.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85080909084",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "395",
                                    "@issue": "10226"
                                },
                                "pagerange": {
                                    "@first": "817",
                                    "@last": "827"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Spring",
                                    "ce:indexed-name": "Spring L.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Wander",
                                    "ce:indexed-name": "Wander S.A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Andre",
                                    "ce:indexed-name": "Andre F."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Moy",
                                    "ce:indexed-name": "Moy B."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "N.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Turner",
                                    "ce:indexed-name": "Turner N.C."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Bardia",
                                    "ce:indexed-name": "Bardia A."
                                }
                            ]},
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Spring LM, Wander SA, Andre F, Moy B, Turner NC, Bardia A. Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future. Lancet. 2020;395(10226):817-827."
                    },
                    {
                        "ref-fulltext": "Petrelli F, Ghidini A, Pedersini R, et al. Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials. Breast Cancer Res Treat. 2019;174(3):597-604.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85060209069",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "174",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "597",
                                    "@last": "604"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Petrelli",
                                        "ce:indexed-name": "Petrelli F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Ghidini",
                                        "ce:indexed-name": "Ghidini A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Pedersini",
                                        "ce:indexed-name": "Pedersini R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Breast Cancer Res Treat"
                        },
                        "ce:source-text": "Petrelli F, Ghidini A, Pedersini R, et al. Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials. Breast Cancer Res Treat. 2019;174(3):597-604."
                    },
                    {
                        "ref-fulltext": "Slamon DJ, Neven P, Chia S, et al. Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: MONALEESA-3. J Clin Oncol. 2018;36(24):2465-2472.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: MONALEESA-3"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85050815779",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "36",
                                    "@issue": "24"
                                },
                                "pagerange": {
                                    "@first": "2465",
                                    "@last": "2472"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Slamon",
                                        "ce:indexed-name": "Slamon D.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Neven",
                                        "ce:indexed-name": "Neven P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Chia",
                                        "ce:indexed-name": "Chia S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Slamon DJ, Neven P, Chia S, et al. Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: MONALEESA-3. J Clin Oncol. 2018;36(24):2465-2472."
                    },
                    {
                        "ref-fulltext": "Slamon DJ, Neven P, Chia S, et al. Overall survival with ribociclib plus fulvestrant in advanced breast cancer. N Engl J Med. 2020;382(6):514-524.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Overall survival with ribociclib plus fulvestrant in advanced breast cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85079075053",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "382",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "514",
                                    "@last": "524"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Slamon",
                                        "ce:indexed-name": "Slamon D.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Neven",
                                        "ce:indexed-name": "Neven P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Chia",
                                        "ce:indexed-name": "Chia S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Slamon DJ, Neven P, Chia S, et al. Overall survival with ribociclib plus fulvestrant in advanced breast cancer. N Engl J Med. 2020;382(6):514-524."
                    },
                    {
                        "ref-fulltext": "Bellet M, Ahmad F, Villanueva R, et al. Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication. Ther Adv Med Oncol. 2019;11:175883591983386. doi:10.1177/1758835919833867",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1177/1758835919833867",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cnr21575-cit-0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85066835008",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "11"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Bellet",
                                        "ce:indexed-name": "Bellet M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Ahmad",
                                        "ce:indexed-name": "Ahmad F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Villanueva",
                                        "ce:indexed-name": "Villanueva R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ther Adv Med Oncol"
                        },
                        "ce:source-text": "Bellet M, Ahmad F, Villanueva R, et al. Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication. Ther Adv Med Oncol. 2019;11:175883591983386. doi:10.1177/1758835919833867"
                    },
                    {
                        "ref-fulltext": "Yu J, Petrie ID, Levy RH, Ragueneau-Majlessi I. Mechanisms and clinical significance of pharmacokinetic-based drug-drug interactions with drugs approved by the U.S. Food and Drug Administration in 2017. Drug Metab Dispos. 2019;47(2):135-144.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Mechanisms and clinical significance of pharmacokinetic-based drug-drug interactions with drugs approved by the U.S. Food and Drug Administration in 2017"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059795667",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "47",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "135",
                                    "@last": "144"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Yu",
                                    "ce:indexed-name": "Yu J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "I.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Petrie",
                                    "ce:indexed-name": "Petrie I.D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Levy",
                                    "ce:indexed-name": "Levy R.H."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Ragueneau-Majlessi",
                                    "ce:indexed-name": "Ragueneau-Majlessi I."
                                }
                            ]},
                            "ref-sourcetitle": "Drug Metab Dispos"
                        },
                        "ce:source-text": "Yu J, Petrie ID, Levy RH, Ragueneau-Majlessi I. Mechanisms and clinical significance of pharmacokinetic-based drug-drug interactions with drugs approved by the U.S. Food and Drug Administration in 2017. Drug Metab Dispos. 2019;47(2):135-144."
                    },
                    {
                        "ref-fulltext": "König J, Müller F, Fromm MF. Transporters and drug-drug interactions: important determinants of drug disposition and effects. Pharmacol Rev. 2013;65(3):944-966.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Transporters and drug-drug interactions: important determinants of drug disposition and effects"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84878359254",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "65",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "944",
                                    "@last": "966"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "König",
                                    "ce:indexed-name": "Konig J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Müller",
                                    "ce:indexed-name": "Muller F."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Fromm",
                                    "ce:indexed-name": "Fromm M.F."
                                }
                            ]},
                            "ref-sourcetitle": "Pharmacol Rev"
                        },
                        "ce:source-text": "König J, Müller F, Fromm MF. Transporters and drug-drug interactions: important determinants of drug disposition and effects. Pharmacol Rev. 2013;65(3):944-966."
                    },
                    {
                        "ref-fulltext": "Thill M, Schmidt M. Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer. Ther Adv Med Oncol. 2018;10:175883591879332. doi:10.1177/1758835918793326",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1177/1758835918793326",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "cnr21575-cit-0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85054585968",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "10"}},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Thill",
                                    "ce:indexed-name": "Thill M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Schmidt",
                                    "ce:indexed-name": "Schmidt M."
                                }
                            ]},
                            "ref-sourcetitle": "Ther Adv Med Oncol"
                        },
                        "ce:source-text": "Thill M, Schmidt M. Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer. Ther Adv Med Oncol. 2018;10:175883591879332. doi:10.1177/1758835918793326"
                    },
                    {
                        "ref-fulltext": "Giacomini KM, Huang SM, Tweedie DJ, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9(3):215-236.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Membrane transporters in drug development"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "77649216536",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "215",
                                    "@last": "236"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Giacomini",
                                        "ce:indexed-name": "Giacomini K.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang S.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Tweedie",
                                        "ce:indexed-name": "Tweedie D.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Rev Drug Discov"
                        },
                        "ce:source-text": "Giacomini KM, Huang SM, Tweedie DJ, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9(3):215-236."
                    },
                    {
                        "ref-fulltext": "Nersesjan V, Hansen K, Krag T, Duno M, Jeppesen TD. Palbociclib in combination with simvastatin induce severe rhabdomyolysis: a case report. BMC Neurol. 2019;19(1):1-7.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Palbociclib in combination with simvastatin induce severe rhabdomyolysis: a case report"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85073720169",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "19",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "7"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Nersesjan",
                                    "ce:indexed-name": "Nersesjan V."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Hansen",
                                    "ce:indexed-name": "Hansen K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Krag",
                                    "ce:indexed-name": "Krag T."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Duno",
                                    "ce:indexed-name": "Duno M."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "T.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Jeppesen",
                                    "ce:indexed-name": "Jeppesen T.D."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Neurol"
                        },
                        "ce:source-text": "Nersesjan V, Hansen K, Krag T, Duno M, Jeppesen TD. Palbociclib in combination with simvastatin induce severe rhabdomyolysis: a case report. BMC Neurol. 2019;19(1):1-7."
                    },
                    {
                        "ref-fulltext": "Sledge GW Jr, Toi M, Neven P, et al. MONARCH 2: abemaciclib in combination with fulvestrant in women with HR+/HER2− advanced breast cancer who had progressed while receiving endocrine therapy. J Clin Oncol. 2017;35(25):2875-2884.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "MONARCH 2: abemaciclib in combination with fulvestrant in women with HR+/HER2− advanced breast cancer who had progressed while receiving endocrine therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85027966887",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "35",
                                    "@issue": "25"
                                },
                                "pagerange": {
                                    "@first": "2875",
                                    "@last": "2884"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Sledge",
                                        "ce:suffix": "Jr.",
                                        "ce:indexed-name": "Sledge G.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Toi",
                                        "ce:indexed-name": "Toi M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Neven",
                                        "ce:indexed-name": "Neven P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Sledge GW Jr, Toi M, Neven P, et al. MONARCH 2: abemaciclib in combination with fulvestrant in women with HR+/HER2− advanced breast cancer who had progressed while receiving endocrine therapy. J Clin Oncol. 2017;35(25):2875-2884."
                    },
                    {
                        "ref-fulltext": "Chappell JC, Turner PK, Pak YA, et al. Abemaciclib inhibits renal tubular secretion without changing glomerular filtration rate. Clin Pharmacol Ther. 2019;105(5):1187-1195.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Abemaciclib inhibits renal tubular secretion without changing glomerular filtration rate"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85059274865",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "105",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "1187",
                                    "@last": "1195"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Chappell",
                                        "ce:indexed-name": "Chappell J.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Turner",
                                        "ce:indexed-name": "Turner P.K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Pak",
                                        "ce:indexed-name": "Pak Y.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Pharmacol Ther"
                        },
                        "ce:source-text": "Chappell JC, Turner PK, Pak YA, et al. Abemaciclib inhibits renal tubular secretion without changing glomerular filtration rate. Clin Pharmacol Ther. 2019;105(5):1187-1195."
                    },
                    {
                        "ref-fulltext": "Pabla N, Gibson AA, Buege M, et al. Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions. Proc Natl Acad Sci USA. 2015;112(16):5231-5236.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84928328171",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "112",
                                    "@issue": "16"
                                },
                                "pagerange": {
                                    "@first": "5231",
                                    "@last": "5236"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Pabla",
                                        "ce:indexed-name": "Pabla N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Gibson",
                                        "ce:indexed-name": "Gibson A.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Buege",
                                        "ce:indexed-name": "Buege M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Proc Natl Acad Sci USA"
                        },
                        "ce:source-text": "Pabla N, Gibson AA, Buege M, et al. Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions. Proc Natl Acad Sci USA. 2015;112(16):5231-5236."
                    },
                    {
                        "ref-fulltext": "Wilson BE, Mok K, Kiely BE, Nguyen R, Moylan E. Association between ribociclib and changes in creatinine in patients with hormone receptor positive metastatic breast cancer. Intern Med J. 2019;49(11):1438-1442.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Association between ribociclib and changes in creatinine in patients with hormone receptor positive metastatic breast cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074849585",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "49",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1438",
                                    "@last": "1442"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Wilson",
                                    "ce:indexed-name": "Wilson B.E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Mok",
                                    "ce:indexed-name": "Mok K."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "B.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Kiely",
                                    "ce:indexed-name": "Kiely B.E."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Nguyen",
                                    "ce:indexed-name": "Nguyen R."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Moylan",
                                    "ce:indexed-name": "Moylan E."
                                }
                            ]},
                            "ref-sourcetitle": "Intern Med J"
                        },
                        "ce:source-text": "Wilson BE, Mok K, Kiely BE, Nguyen R, Moylan E. Association between ribociclib and changes in creatinine in patients with hormone receptor positive metastatic breast cancer. Intern Med J. 2019;49(11):1438-1442."
                    },
                    {
                        "ref-fulltext": "O'Shaughnessy J, Petrakova K, Sonke GS, et al. Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial. Breast Cancer Res Treat. 2018;168(1):127-134.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85034667232",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "168",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "127",
                                    "@last": "134"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "O'Shaughnessy",
                                        "ce:indexed-name": "O'Shaughnessy J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Petrakova",
                                        "ce:indexed-name": "Petrakova K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Sonke",
                                        "ce:indexed-name": "Sonke G.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Breast Cancer Res Treat"
                        },
                        "ce:source-text": "O'Shaughnessy J, Petrakova K, Sonke GS, et al. Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial. Breast Cancer Res Treat. 2018;168(1):127-134."
                    },
                    {
                        "ref-fulltext": "Tripathy D, Im SA, Colleoni M, et al. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial. Lancet Oncol. 2018;19(7):904-915.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85047257394",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "19",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "904",
                                    "@last": "915"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Tripathy",
                                        "ce:indexed-name": "Tripathy D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Im",
                                        "ce:indexed-name": "Im S.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Colleoni",
                                        "ce:indexed-name": "Colleoni M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Tripathy D, Im SA, Colleoni M, et al. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial. Lancet Oncol. 2018;19(7):904-915."
                    },
                    {
                        "ref-fulltext": "Gong L, Goswami S, Giacomini KM, Altman RB, Klein TE. Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2012;22(11):820-827.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Metformin pathways: pharmacokinetics and pharmacodynamics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0018",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84867575707",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "820",
                                    "@last": "827"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Gong",
                                    "ce:indexed-name": "Gong L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Goswami",
                                    "ce:indexed-name": "Goswami S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Giacomini",
                                    "ce:indexed-name": "Giacomini K.M."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Altman",
                                    "ce:indexed-name": "Altman R.B."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "T.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Klein",
                                    "ce:indexed-name": "Klein T.E."
                                }
                            ]},
                            "ref-sourcetitle": "Pharmacogenet Genomics"
                        },
                        "ce:source-text": "Gong L, Goswami S, Giacomini KM, Altman RB, Klein TE. Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2012;22(11):820-827."
                    },
                    {
                        "ref-fulltext": "Teale KF, Devine A, Stewart H, Harper NJ. The management of metformin overdose. Anaesthesia. 1998;53(7):698-701.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1998"},
                            "ref-title": {"ref-titletext": "The management of metformin overdose"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0019",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0031829840",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "53",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "698",
                                    "@last": "701"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Teale",
                                    "ce:indexed-name": "Teale K.F."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Devine",
                                    "ce:indexed-name": "Devine A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Stewart",
                                    "ce:indexed-name": "Stewart H."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "N.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Harper",
                                    "ce:indexed-name": "Harper N.J."
                                }
                            ]},
                            "ref-sourcetitle": "Anaesthesia"
                        },
                        "ce:source-text": "Teale KF, Devine A, Stewart H, Harper NJ. The management of metformin overdose. Anaesthesia. 1998;53(7):698-701."
                    },
                    {
                        "ref-fulltext": "Spring LM, Zangardi ML, Moy B, Bardia A. Clinical management of potential toxicities and drug interactions related to cyclin-dependent kinase 4/6 inhibitors in breast cancer: practical considerations and recommendations. Oncologist. 2017;22(9):1039-1048.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Clinical management of potential toxicities and drug interactions related to cyclin-dependent kinase 4/6 inhibitors in breast cancer: practical considerations and recommendations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "cnr21575-cit-0020",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85029634475",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1039",
                                    "@last": "1048"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Spring",
                                    "ce:indexed-name": "Spring L.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Zangardi",
                                    "ce:indexed-name": "Zangardi M.L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Moy",
                                    "ce:indexed-name": "Moy B."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Bardia",
                                    "ce:indexed-name": "Bardia A."
                                }
                            ]},
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Spring LM, Zangardi ML, Moy B, Bardia A. Clinical management of potential toxicities and drug interactions related to cyclin-dependent kinase 4/6 inhibitors in breast cancer: practical considerations and recommendations. Oncologist. 2017;22(9):1039-1048."
                    }
                ]
            }}
        }
    },
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85118498186",
        "dc:description": "Background: Ribociclib, one of the cyclin-dependent kinases (CDK) 4 and 6 inhibitors, in combination with endocrine therapies has been approved in the treatment of hormonal receptor positive, HER-2 negative metastatic breast cancer worldwide. Long-term usage of ribociclib with concomitant drugs, potential drug\u2013drug interaction may develop which can limit the therapeutic value of CDK4/6 inhibitor. Case: A 62-year-old with history of non-insulin dependent diabetic, dyslipidemia, and essential hypertension was diagnosed with HR-positive, HER-2 negative metastatic breast cancer and treated with fulvestrant plus ribociclib. Four weeks after administration, elevated serum creatinine was observed, and then severe lactic acidosis with acute respiratory failure was subsequently reported. Ribociclib and fulvestrant were temporarily discontinued. Three days after renal replacement therapy, her clinical was stabilized. Combination ribociclib with metformin resulted in high plasma metformin levels and dangerous consequences. Hence, special precaution should be considered during concomitant treatment with sensitive transporter substrates. Conclusion: Metformin associated lactic acidosis may potentially occur after combination with ribocilib, an uncommon but lethal complication from the interaction of these drugs, especially in patients who had preexisting renal impairment.",
        "pubmed-id": "34739192",
        "prism:coverDate": "2022-08-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85118498186",
        "dc:creator": {"author": [{
            "ce:given-name": "Chalita",
            "preferred-name": {
                "ce:given-name": "Chalita",
                "ce:initials": "C.",
                "ce:surname": "Lagampan",
                "ce:indexed-name": "Lagampan C."
            },
            "@seq": "1",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Lagampan",
            "@auid": "57218290182",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218290182",
            "ce:indexed-name": "Lagampan C."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85118498186"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85118498186&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85118498186&origin=inward"
            }
        ],
        "source-id": "21100983151",
        "citedby-count": "0",
        "prism:volume": "5",
        "subtype": "ar",
        "dc:title": "Lactic acidosis, a potential toxicity from drug\u2013drug interaction related to concomitant ribociclib and metformin in preexisting renal insufficiency: A case report",
        "openaccess": "1",
        "prism:issn": "25738348",
        "publishercopyright": "© 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC.",
        "article-number": "e1575",
        "prism:issueIdentifier": "8",
        "subtypeDescription": "Article",
        "prism:publicationName": "Cancer Reports",
        "openaccessFlag": "true",
        "prism:doi": "10.1002/cnr2.1575",
        "dc:identifier": "SCOPUS_ID:85118498186",
        "dc:publisher": "John Wiley and Sons Inc"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "concomitant"
        },
        {
            "@_fa": "true",
            "$": "drug\u2013drug interaction"
        },
        {
            "@_fa": "true",
            "$": "lactic acidosis"
        },
        {
            "@_fa": "true",
            "$": "renal insufficiency"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Chalita",
            "preferred-name": {
                "ce:given-name": "Chalita",
                "ce:initials": "C.",
                "ce:surname": "Lagampan",
                "ce:indexed-name": "Lagampan C."
            },
            "@seq": "1",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Lagampan",
            "@auid": "57218290182",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218290182",
            "ce:indexed-name": "Lagampan C."
        },
        {
            "ce:given-name": "Nattaya",
            "preferred-name": {
                "ce:given-name": "Nattaya",
                "ce:initials": "N.",
                "ce:surname": "Poovorawan",
                "ce:indexed-name": "Poovorawan N."
            },
            "@seq": "2",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Poovorawan",
            "@auid": "57192107420",
            "author-url": "https://api.elsevier.com/content/author/author_id/57192107420",
            "ce:indexed-name": "Poovorawan N."
        },
        {
            "ce:given-name": "Napa",
            "preferred-name": {
                "ce:given-name": "Napa",
                "ce:initials": "N.",
                "ce:surname": "Parinyanitikul",
                "ce:indexed-name": "Parinyanitikul N."
            },
            "@seq": "3",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Parinyanitikul",
            "@auid": "36554719100",
            "author-url": "https://api.elsevier.com/content/author/author_id/36554719100",
            "ce:indexed-name": "Parinyanitikul N."
        }
    ]}
}}